Back to BL BAUPOST GROUP LLC/MA
TBPHShowing 1 of 24 quarters
Position history for BLBAUPOST GROUP LLC/MA's holdings in THERAVANCE BIOPHARMA INC
No. The Baupost Group exited its TBPH (Theravance Biopharma) position in Q3 2024. Its Q2 2024 13F listed 4,200,021 shares worth $35.6M. The Baupost Group already held TBPH in its Q4 2018 13F, the earliest on record, and held it in 23 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of TBPH: FMR LLC